Antigen Transduced T Cells Used as a Delivery System for Antigens

a technology of antigen transduction and delivery system, which is applied in the direction of antibody medical ingredients, dsdna viruses, immunological disorders, etc., to achieve the effect of monitoring the effectiveness of vaccination and stimulating the immune response against transgen

Inactive Publication Date: 2008-11-20
MOLMED SPA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007]The present invention relates to manipulated T cells that when introduced into a patient are able to bring antigens, such as tumor, bacterial or viral antigens, into contact with professional antigen presenting cells (APCs). More particularly, the invention provides a transduced T cell containing an exogenous (or foreign) gene encoding an antigen to stimulate a response against the antigen, and T cell loaded with an antigenic polypeptide to stimulate a response. The T cell may also comprise a further antigen such as HSV-Tk which may be used to monitor vaccination effectiveness. Conveniently the T cells are prepared in vitro and when injected, or otherwise introduced in vivo, carry the transgene products to professional antigen presenting cells, thus stimulating the immune response against the transgene product. The invention also provides a methodology whereby one can monitor the immunological status of the patient. The present invention further provides a culturing method for T cells.

Problems solved by technology

However, the majority of the human gene therapy trials approved so far involve treatment of acquired diseases, such cancer and AIDS.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antigen Transduced T Cells Used as a Delivery System for Antigens
  • Antigen Transduced T Cells Used as a Delivery System for Antigens
  • Antigen Transduced T Cells Used as a Delivery System for Antigens

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0204]The infusion of donor lymphocytes in the context of allogeneic bone marrow transplantation (allo-BMT) for leukaemia is an established strategy to control tumor relapse and viral infections. To circumvent the inherent risk of graft-vs-host disease (GVHD) BM-donor lymphocytes can be transduced by a suicide gene, conferring sensitivity to a drug, that may allow the selective elimination of the transduced cells for both therapeutic and safety issues.

[0205]Peripheral blood mononuclear cells (PBMC) were isolated by Lymphoprep (Nycomed, Oslo, Norvay) density-gradient centrifugation from all the BM-donors and the healthy controls studied.

[0206]Activation. Two different activation signals were used to activate T cells (hereafter referred to as T blasts): phytoemoagglutinine (PHA) 2 μg / ml (Boehringer Mannheim); anti-CD3 mAb (OKT3) 30 ng / ml (Orthoclone, Milan, Italy); OKT3 (30 ng / ml). Activated T cells were cultured at 1×106 cells / ml, in RPMI 1640 supplemented with 5% autologous serum in...

example 2

[0213]Further studies were carried out to identify the target antigens of the immune response. Effector cells derived from one of the patient were tested against autologous T blasts expressing single components of the vector. T blasts expressing HSV-TK were lysed while target cells expressing the ΔLNGFr were not recognized at all (FIG. 2). Analogous results were obtained with effector cells isolated from other patients.

example 3

[0214]The results from Example 1 (i.e. generation of HSV-TK-specific immunity) were analyzed in relation to the time of the infusions and the number of engineered T cells infused. Time of the infusions, measured as months from bone marrow transplantation (abscissa) and number of engineered T cells injected (ordinate), are presented. The development of an immune response against the transduced cells was evaluated by ex vivo stimulation of PBLs against autologous-transduced and allogeneic T cells as described in example 1. In the presence of a positive anti-allo immune response the patient was considered not immunized (empty symbols) or immunized (full symbols) to the transgene depending on the presence of a cytolytic activity against the transduced cells. Data points represent the cell infusion responsible (full symbols) or not responsible (empty symbols) for the induction of the immune response. For patient UPN-15 two different time points are represented. These results suggested th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A delivery system comprising a T cell comprising at least one antigen capable of loading antigen-presenting-cells with the antigen.

Description

FIELD OF THE INVENTION[0001]The present invention relates to a delivery system for an antigen in the form of a T cell, the use of such a T cell to monitor an immune response and a method of preparing the T cell.BACKGROUND OF THE INVENTION[0002]Gene transfer into human cells is being investigated for the treatment of a variety of genetic and acquired human diseases. Genetic diseases, due to a single-gene defect, were originally proposed as the primary targets of gene therapy. However, the majority of the human gene therapy trials approved so far involve treatment of acquired diseases, such cancer and AIDS. One approach to tumor gene therapy relies on the stimulation of the host immune system against tumor antigens by vaccination of the patient with genetically modified tumor cells, in which the transgene (cytokine, allo-HLA, etc.) is aimed at boosting their immunogenicity. An alternative approach is based on the adoptive transfer of ex vivo generated tumor-specific effectors. The inf...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K39/00C12N5/06A61K35/12A61P37/00A61K39/12A61K39/245C12N5/08
CPCA61K39/0011A61K39/245A61K2039/5156A61K2039/5158C12N2710/16634A61K39/12A61P31/00A61P35/00A61P37/00A61K39/4611A61K2239/57A61K39/46434A61K2239/26A61K39/4621A61K39/464486A61K39/464838C12N5/16A61K39/02C12N5/10
InventorTRAVERSARI, CATIABORDIGNON, CLAUDIO
OwnerMOLMED SPA